Tracy Meffen has served as SVP Alliance Programs & Head of QA/RA and Operations of Genevant Sciences Corporation since April 2022. Previously, she held the position Vice President, Quality & Regulatory Affairs. Prior to joining Genevant at its inception in April 2018, Tracy served in QA and RA management roles with Arbutus Biopharma, Lungpacer Medical, and at McKesson. She brings over 25 years of experience in drug and medical device development at various organizations including INEX, Eli Lilly and Genzyme. Tracy holds a MS in Regulatory Affairs from Northeastern University and a BSc in Chemistry from the University of Hull as well as RAC credentials for the United States, Europe and Canada.